Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
16.03
-0.17 (-1.05%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Orthofix Medical Revenue
Orthofix Medical had revenue of $198.62M in the quarter ending June 30, 2024, with 6.20% growth. This brings the company's revenue in the last twelve months to $771.65M, up 28.94% year-over-year. In the year 2023, Orthofix Medical had annual revenue of $746.64M with 62.06% growth.
Revenue (ttm)
$771.65M
Revenue Growth
+28.94%
P/S Ratio
0.78
Revenue / Employee
$472,245
Employees
1,634
Market Cap
611.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
Dec 31, 2019 | 459.96M | 6.91M | 1.53% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fulgent Genetics | 290.71M |
Pharming Group | 277.56M |
Entrada Therapeutics | 239.40M |
Axogen | 173.48M |
CureVac | 70.57M |
Allogene Therapeutics | 65.00K |
OFIX News
- 2 days ago - Orthofix to Participate in Stifel 2024 Healthcare Conference - Business Wire
- 2 days ago - The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Orthofix Medical Inc. - Accesswire
- 3 days ago - Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Help The Schall Law Firm - Accesswire
- 3 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - PRNewsWire
- 5 days ago - Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 6 days ago - DEADLINE NEXT WEEK: Berger Montague Advises Orthofix Medical (NASDAQ: OFIX) Investors to Contact the Firm Before October 21, 2024 - GlobeNewsWire
- 7 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in Orthofix Medical Inc. Lawsuit – OFIX - GlobeNewsWire
- 8 days ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - PRNewsWire